Información bibliográfica
GuíaWHO consolidated guidelines for the management of common childhood illness: management of sickle-cell disease in children and adolescents
Año de publicación2026
Institución emisoraWorld Health Organization
Recomendación
Nueva
In children and adolescents (aged 0–19 years) with sickle-cell disease (SCD), experiencing acute painful crises, the use of non-steroidal anti-inflammatory drugs (NSAIDs) is suggested for initial pain management.
Recomendado a favor
Condicional
Certeza de la evidencia
Muy baja